8-K
filed June 2, 2026, 4:15 PM ET
ticker CTKB
CIK 0001831915
leadership
confidence high
sentiment neutral
materiality 0.50
Cytek Biosciences SVP Global Sales Philippe Busque resigns effective June 5
Cytek Biosciences, Inc.
- Philippe Busque, Ph.D., SVP Global Sales and Services, resigned effective June 5, 2026.
- Resignation is to pursue another career opportunity; not due to disagreement with company operations.
- No successor or interim appointment announced in the filing.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-253538
- form_type
- 8-K
- ticker
- CTKB
- cik
- 0001831915
- company_name
- Cytek Biosciences, Inc.
- filed_at
- 2026-06-02T20:15:52+00:00
- discovered_at
- 2026-06-02T20:17:06.756147+00:00
- generated_at
- 2026-06-02T20:17:52.634735+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-253538
- json_url
- https://secwatch.observer/filing/0001193125-26-253538.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-253538.md
- text_url
- https://secwatch.observer/filing/0001193125-26-253538.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1831915/000119312526253538/0001193125-26-253538-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1831915/000119312526253538/d161903d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
NUE
Nucor EVP David Sumoski to retire June 13, 2026; receives $308,851/month for 24 months
NUCOR CORP
June 2, 2026, 5:11 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
On May 28, 2026, the Company and Mr. Sumoski entered into a Retirement, Separation, Waiver and Release Agreement (the “Retirement Agreement”) in connection with Mr. Sumoski’s retirement from employment with the Company, effective June 13, 2026.
Filing page
SEC filing
BSTT
Zaneta Koplewicz resigns as Co-President and Director of Blackstone Real Estate Income Trust
Blackstone Real Estate Income Trust, Inc.
June 2, 2026, 5:08 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
On June 2, 2026, Zaneta Koplewicz resigned from Blackstone Real Estate Income Trust, Inc. (the “Company”) as Co-President, Head of Shareholder Relations and as a member of the Company’s Board of Directors (the “Board”), effective June 24, 2026.
Filing page
SEC filing
VWAV
VisionWave appoints Einav Eliraz as CFO of subsidiary VisionWave IL; grants 500K share options
VisionWave Holdings, Inc.
June 2, 2026, 5:01 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
On June 1, 2026, VisionWave IL Ltd. (“VisionWave IL”), a wholly-owned subsidiary of VisionWave Holdings, Inc. (the “Company”), entered into an Employment Agreement with Mr. Einav Eliraz pursuant to which Mr. Eliraz was appointed Chief Financial Officer (“CFO”) of VisionWave IL, effective June 1, 2026.
Filing page
SEC filing
DIN
Dine Brands appoints Lawrence Y. Kim as Chief Commercial Officer effective June 1, 2026
Dine Brands Global, Inc.
June 2, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
appointed Lawrence Y. Kim, President, IHOP Business Unit, to the additional position of Chief Commercial Officer of the Corporation, effective as of June 1, 2026.
Filing page
SEC filing
CUE
Cue Biopharma appoints new directors, chief legal officer, and accounting officer; board size reduced
Cue Biopharma, Inc.
June 2, 2026, 4:45 PM ET
leadership
Items 5.02, 8.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
On May 29, 2026, Cue Biopharma, Inc. (the “Company”) and each of Jill Broadfoot, Peter Kiener, Frank Morich and Patrick Verheyen mutually agreed that Messrs. Kiener, Morich and Verheyen and Ms. Broadfoot would resign as members of the Board of Directors of the Company (the “Board”) and as members of the committees of the Board on which they serve, effective immediately.
Filing page
SEC filing
CYCU
Cycurion appoints Ana Garcia as CFO; Alvin McCoy III transitions to strategic advisor
Cycurion, Inc.
June 2, 2026, 4:43 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
the Company also announced the appointment of Ana Garcia as its new Chief Financial Officer, effective June 1, 2026.
Filing page
SEC filing
YUM
YUM! Brands COO/CPO Tracy Skeans to transition Nov 1, 2026, retire March 1, 2028
YUM BRANDS INC
June 2, 2026, 4:33 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
On June 2, 2026, YUM! Brands, Inc. (the “Company”) announced that Tracy Skeans will transition from her roles as Chief Operating Officer and Chief People & Culture Officer effective on November 1, 2026 (the “Transition Date”).
Filing page
SEC filing
Cornerstone Building Brands, Inc.
Cornerstone Building Brands names Richard Dirkson as Corporate Controller; CAO departs
Cornerstone Building Brands, Inc.
June 2, 2026, 10:32 AM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 27, 2026, Philippe Busque, Ph.D. submitted his resignation from his position as the Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc. (the “Company”), effective as of June 5, 2026, to pursue another career opportunity.
Comparable filing
On May 27, 2026, the Company appointed Richard Dirkson as Senior Vice President, Corporate Controller (principal accounting officer) of the Company, effective May 28, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.